Evaluation of the effectiveness and safety of sevoflurane or propofol combined with remifentanil in elderly laparoscopic cholecystectomy

Status

Recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2100045111

Enrollment

Unknown

Registered

2021-04-07

Start date

2021-07-06

Completion date

Unknown

Last updated

2021-11-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gallbladder disease

Interventions

Control group:Propofol + remifentanil anesthesia

Experimental group:Sevoflurane + remifentanil anesthesia

Eligibility

Sex/Gender

All

Age

60 Years to 85 Years

Inclusion criteria

Inclusion criteria: 1. Aged between 60-85 years, no gender limit; 2. ASA grade II-III; 3. Patients undergoing elective laparoscopic cholecystectomy; 4. No alcohol or drug dependence history.

Exclusion criteria

Exclusion criteria: 1. Patients with neurological diseases and mental illness; 2. Patients with a history of lobectomy; 3. Patients with a history of inhalation anesthesia surgery in the past 3 months; 4. With drug allergies, severe heart, lung, and kidneys cases of dysfunction.

Design outcomes

Primary

Measure	Time frame
Anesthesia effect;Safety;Postoperative cognitive function changes;	—

Secondary

Measure	Time frame
comparison of restlessness and anxiety;	—

Countries

China

Contacts

Public ContactYou Shuai

People's Hospital of Shapingba District, Chongqing

197372465@qq.com+86 15823826973

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026